Lance Platform

SEVEN NOVEL IMMUNOMETABOLIC TARGETS
BT-11
Discovery
IND
Initiation of
Phase 1
Phase 2
ready
Phase 3
24 Months
30 Months
NX-13
BT-104
BT-111
NX-66
PX-69
NX-73
Discovery
IND
Initiation of
Phase 1
Phase 2
ready
Phase 3
18 Months
(for NX-13, all others projected)
24 Months
(projected)